| Over the past | Total investment | Would've become | Historic returns | Returns |
|---|---|---|---|---|
| 1 year | ₹60,000 | ₹70,367 | +17.28% | |
| 3 years | ₹1,80,000 | ₹2,42,819 | +34.90% | |
| 5 years | ₹3,00,000 | ₹5,37,720 | +79.24% | |
| 10 years | ₹6,00,000 | ₹18,19,330 | +203.22% |
| Name | Sector | Instruments | Assets |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 10.55% |
| Divi's Laboratories Ltd | Healthcare | Equity | 8.38% |
| Max Healthcare Institute Ltd | Healthcare | Equity | 4.96% |
| Ami Organics Ltd | Healthcare | Equity | 4.95% |
| Apollo Hospitals Enterprise Ltd | Healthcare | Equity | 4.87% |
| Laurus Labs Ltd | Healthcare | Equity | 4.76% |
| Cipla Ltd | Healthcare | Equity | 4.36% |
| Repo | Unspecified | Repo | 4.14% |
| Torrent Pharmaceuticals Ltd | Healthcare | Equity | 4.11% |
| Aurobindo Pharma Ltd | Healthcare | Equity | 3.10% |
| Gland Pharma Ltd | Healthcare | Equity | 3.06% |
| Aster DM Healthcare Ltd | Healthcare | Equity | 3.03% |
| Anthem Biosciences Ltd. | Healthcare | Equity | 2.57% |
| Sai Life Sciences Ltd. | Healthcare | Equity | 2.57% |
| Paras Healthcare Ltd. | Healthcare | Equity | 2.49% |
| CORONA Remedies Ltd. | Healthcare | Equity | 2.41% |
| Sudeep Pharma Ltd. | Healthcare | Equity | 2.39% |
| Fortis Healthcare Ltd | Healthcare | Equity | 2.28% |
| Biocon Ltd | Healthcare | Equity | 2.17% |
| Jupiter Life Line Hospitals Ltd. | Healthcare | Equity | 2.12% |
| Aether Industries Ltd | Materials | Equity | 2.00% |
| Concord Biotech Ltd. | Healthcare | Equity | 1.97% |
| Krishna Institute Of Medical Sciences Ltd | Healthcare | Equity | 1.85% |
| Global Health Ltd | Healthcare | Equity | 1.67% |
| Suven Pharmaceuticals Ltd | Healthcare | Equity | 1.61% |
| Dr. Lal Pathlabs Ltd | Healthcare | Equity | 1.57% |
| Ajanta Pharma Ltd | Healthcare | Equity | 1.56% |
| Poly Medicure Ltd | Healthcare | Equity | 1.53% |
| Innova Captab Ltd. | Healthcare | Equity | 1.41% |
| Healthcare Global Enterprises Ltd | Healthcare | Equity | 1.35% |
| Mankind Pharma Ltd. | Healthcare | Equity | 1.23% |
| Syngene International Ltd | Healthcare | Equity | 1.19% |
| Nephrocare Health Services Ltd. | Healthcare | Equity | 1.01% |
| Manipal Health Enterprises Ltd | Healthcare | Equity | 0.99% |
| Zydus Lifesciences Ltd | Healthcare | Equity | 0.47% |
| Gufic Biosciences Ltd | Healthcare | Equity | 0.27% |
| Abbott India Ltd | Healthcare | Equity | 0.21% |
| GOVERNMENT OF INDIA 36714 364 DAYS TBILL 19NV26 FV RS 100 | Financial | Treasury Bills | 0.05% |
| Novartis India Ltd | Healthcare | Equity | 0.03% |
| Net Payables | Unspecified | Net Payables | -1.28% |
| Name | 3Y | 5Y | 10Y | All |
|---|---|---|---|---|
| Fund returns | +24.8% | +20.9% | +16.1% | +18.4% |
| Category average (Equity Sectoral) | +22.5% | +17.6% | +16.4% | +17.7% |
| Rank (Equity Sectoral) | 2 | 1 | 2 | -- |